
|Articles|September 21, 2010
Supplements and Featured Publications
- New and Emerging Therapies for Multiple Sclerosis and the Role of Managed Care [CME/CPE]
- Volume 16
- Issue 8 Suppl
Posttest: New and Emerging Therapies for Multiple Sclerosis and the Role of Managed Care
Advertisement
Articles in this issue
about 15 years ago
Will the Newer Oral MS Agents Be Welcomed by Managed Care Organizations?about 15 years ago
The Current Landscape and Unmet Needs in Multiple Sclerosisabout 15 years ago
Participating Facultyabout 15 years ago
Emerging Oral Agents for Multiple SclerosisNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Contributor: Engagement Is the Missing Link in Kidney Care—How Payers and Value-Based Partnerships Can Close the Gap
2
Reactivating CCNA2 Gene Enables Adult Heart Cells to Regenerate
3
Remibrutinib Demonstrates Early, Sustained Efficacy and Favorable Safety in CSU
4
FDA Approves Selumetinib for Adults With Neurofibromatosis Type 1
5















































